Analyst Ratings for Regenxbio Inc. (RGNX)
RGNX Rating Summary
RGNX Price Target Summary
- Highest: $45.00 (Clear Street)
- Lowest: $10.00 (Goldman Sachs)
- Average: $23.70
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$23.70 (+170.5%)
* Over Last 12-Mos
Rating Score: 7.8 / 10
Percentile Rank: 81%
Avg. $ Target:
$23.70 (+170.5%)
* Over Last 12-Mos
Rating Score: 7.8 / 10
Percentile Rank: 81%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/7/2026 | Barclays | Eliana Merle | Downgrade | Equalweight (Overweight) |
12.00 (N/A) |
10.50 (8.76) |
-16.57% | Details |
| 4/1/2025 | Clear Street » Updated 3/5/2026 |
Bill Maughan | New Coverage | Buy (N/A) |
45.00 (N/A) |
7.83 (8.76) |
11.88% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
